The International Society on Thrombosis and Haemostasis (ISTH) will recognize 
its landmark 50th anniversary as the leader in the field of thrombosis and 
hemostasis at the ISTH 2019 Congress ( 
https://c212.net/c/link/?t=0&l=en&o=2507224-1&h=3697204848&u=https%3A%2F%2Fwww.isth2019.org%2F&a=ISTH+2019+Congress 
) from July 6-10 in Melbourne, Australia. Under the congress theme of 
"Research, Discovery, Outcomes," more than 5,000 experts from over 90 countries 
in the field will convene at the Melbourne Convention Exhibition Centre (MCEC) 
to present the latest basic, translational and clinical research and discuss 
the diagnostic and therapeutic advances in bleeding and clotting disorders.

Photo - https://mma.prnewswire.com/media/928150/ISTH_2019_MELBOURNE.jpg

"We are very excited to welcome experts to Melbourne from around the world to 
attend the leading scientific event in the field of thrombosis, hemostasis and 
vascular biology," said ISTH 2019 Congress President Prof. Robert Medcalf ( 
https://c212.net/c/link/?t=0&l=en&o=2507224-1&h=2904809642&u=https%3A%2F%2Fwww.isth2019.org%2Fleadership.html&a=ISTH+2019+Congress+President+Prof.+Robert+Medcalf 
). "The ISTH 2019 Congress features a range of groundbreaking research, 
innovative offerings and scientific advances to improve the lives of patients 
worldwide. Furthermore, the congress offers the perfect platform for early 
career professionals and others to obtain the connections and knowledge needed 
to advance their career."

This year, more than 2,136 scientific abstracts from more than 75 countries 
were submitted by clinicians, scientists, academics and students for ISTH 2019. 
Abstracts cover trending scientific topics such as arterial thromboembolism, 
coagulation and anticoagulation, diagnostics and OMICs, fibrinolysis and 
proteolysis, hemophilia and bleeding disorders including transfusion, 
immunothrombosis and vascular biology, nursing, pediatrics, platelets and 
megakaryocytes, platelet disorders, prothrombotic stress, venous 
thromboembolism and women's health.

Opportunity to Preview the Latest Scientific Highlights

The official ISTH 2019 press briefing will take place on Tuesday, July 9, from 
11:00 a.m. – 12:00 p.m. and will provide an overview of the latest key 
scientific evidence and findings presented at the congress.

Moderated by Prof. Philip Hogg from the University of Sydney in Sydney, 
Australia, the press briefing will cover relevant topics such as treatment of 
acute venous thromboembolism in children, subcutaneous prophylaxis in 
hemophilia, screening of deep vein thrombosis, use of filters in severely 
injured patients, gene therapy and more. In addition to the press briefing, 
in-depth presentations on the scientific highlights featured at the ISTH 2019 
press briefing will take place at the following times during the congress:

Late Breaking Abstracts, Session on Monday, July 8 from 10:45 a.m. – 12:00 p.m.

Subcutaneous Prophylaxis with the Anti-TFPI Monoclonal Antibody Concizumab in 
Hemophilia A and Hemophilia A/B with Inhibitors: Phase 2 Trial Results

   -- Presentation Number: LB 01.1 
   -- Presenting Author: Jan Astermark

First-in-human Evidence of Durable Therapeutic Efficacy and Safety of AAV Gene 
Therapy Over Three-years with Valoctocogene Roxaparvovec for Severe Haemophilia 
A (BMN 270-201 Study)

   -- Presentation Number: LB 01.2 
   -- Presenting Author: K. John Pasi

A Multicenter Trial of Vena Cava Filters in Severely-Injured Patients 

   -- Presentation Number: LB 01.3 
   -- Presenting Author: Kwok-Ming Ho

Magnetic Resonance Direct Thrombus Imaging Can Safely Rule Out Recurrent 
Ipsilateral Deep Vein Thrombosis of the Leg - The Theia Study 

   -- Presentation Number: LB 01.4 
   -- Presenting Author: Lisette F. van Dam

Rivaroxaban for the Treatment of Acute Venous Thromboembolism in Children 

   -- Presentation Number: LB 01.5 
   -- Presenting Author: Christoph Male

For the ISTH 2019 full abstracts supplement, click here ( 
https://c212.net/c/link/?t=0&l=en&o=2507224-1&h=1265699227&u=https%3A%2F%2Fonlinelibrary.wiley.com%2Fdoi%2Fepdf%2F10.1002%2Frth2.12227&a=click+here 
).

For more information about the ISTH 2019 Congress, visit www.isth2019.org.

About the ISTH 
Founded in 1969, the ISTH is the leading worldwide not-for-profit organization 
dedicated to advancing the understanding, prevention, diagnosis and treatment 
of thrombotic and bleeding disorders. ISTH is an international professional 
membership organization with more than 5,000 clinicians, researchers and 
educators working together to improve the lives of patients in more than 100 
countries around the world. Among its highly regarded activities and 
initiatives are education and standardization programs, research activities, 
yearly congresses, peer-reviewed publications, expert committees and World 
Thrombosis Day on 13 October. Visit ISTH online at www.isth.org.

SOURCE: International Society on Thrombosis and Haemostasis